Sonoma Pharmaceuticals (SNOA) EPS (Basic) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly EPS (Basic) of -$0.35 for Q1 2026, up 44.82% year-over-year from -$0.24 in Q1 2025, and up 27.84% quarter-over-quarter from -$0.48 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EPS (Basic) (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 44.82% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$1.89 (up 32.32% YoY), while the FY2026 annual figure was -$1.89, up 32.32% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.35, up from -$0.48 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.32 in Q3 2025, with the low at -$12509.7 in Q4 2022.
- The 5-year median for EPS (Basic) is -$1.47 (2023), against an average of -$2392.0.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 768883.23% in 2022, then jumped 99.99% in 2024.
- Sonoma Pharmaceuticals' EPS (Basic) stood at -$12509.7 in 2022, then soared by 99.99% to -$1.59 in 2023, then jumped by 60.08% to -$0.63 in 2024, then advanced by 24.57% to -$0.48 in 2025, then climbed by 27.84% to -$0.35 in 2026.
- Business Quant data shows SNOA's EPS (Basic) at -$0.35 in Q1 2026, -$0.48 in Q4 2025, and -$0.32 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -0.48 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | -0.63 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -1.34 |
| Mar 31, 2024 | -2.35 |
| Dec 31, 2023 | -1.59 |
| Sep 30, 2023 | -5,751.94 |
| Jun 30, 2023 | -5,740.89 |
| Mar 31, 2023 | -7,694.12 |
| Dec 31, 2022 | -12,509.68 |
| Sep 30, 2022 | -6,561.29 |
| Jun 30, 2022 | -5.72 |
| Sep 30, 2021 | -0.85 |
| Jun 30, 2021 | -10.49 |
| Mar 31, 2021 | -2.28 |